ArticleLiver cancer2023

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.

Bin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.